24478-324 : Quillivant 750 mg/150ml Oral Suspension, Extended Release

NDC:	24478-324
Labeler:	Nextwave Pharmaceuticals, Inc
Product Type:	Human Prescription Drug
Drug Name:	Quillivant XR
Dosage Form:	Oral Suspension, Extended Release
Application #:	NDA202100
Rev. Date:	Jan 4, 2013
CSA Schedule:	CII (US) [1]

^[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

NDC Package Codes:

• 24478-324-06: 1 BOTTLE IN 1 CARTON (24478‑324‑06) > 150 ML IN 1 BOTTLE

Active Ingredients:

• Methylphenidate Hydrochloride

Pharmaceutical Classes:

• Central Nervous System Stimulant [EPC]
• Central Nervous System Stimulation [PE]

Related Products:

Based on records with the same trade name.

• 24478-321 Quillivant 300 mg/60ml Oral Suspension, Extended Release by Nextwave Pharmaceuticals, Inc
• 24478-322 Quillivant 600 mg/120ml Oral Suspension, Extended Release by Nextwave Pharmaceuticals, Inc
• 24478-323 Quillivant 900 mg/180ml Oral Suspension, Extended Release by Nextwave Pharmaceuticals, Inc
• 24478-190 Quillivant 300 mg/60ml Oral Powder, for Suspension by Nextwave Pharmaceuticals, Inc.
• 24478-200 Quillivant 600 mg/120ml Oral Powder, for Suspension by Nextwave Pharmaceuticals, Inc.
• 24478-205 Quillivant 750 mg/150ml Oral Powder, for Suspension by Nextwave Pharmaceuticals, Inc.
• 24478-210 Quillivant 900 mg/180ml Oral Powder, for Suspension by Nextwave Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:



< Prev: 24478-323Next: 24486-200 >

Related Discussions: